V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007139 | 240004459 | null | 57 | Disease modification (D) | null | 2015-12-06 | Chlorambucil | N | N | 240032634 | CHLORAMBUCIL |
| 240007140 | 240004459 | 1.63 | 50.5 | Palliative (P) | 2015-06-10 | 2015-06-10 | CHLORAMBUCIL + RITUXIMAB | N | N | 240032634 | CHLORAMBUCIL + RITUXIMAB |
| 240007141 | 240004460 | 1.7 | 63.6 | null | 2014-12-22 | 2014-12-25 | Bendamustine +/- Prednisolone | Y | N | 240032642 | BENDAMUSTINE |
| 240007142 | 240004460 | 1.57 | 61 | Curative (C) | 2013-06-15 | 2013-06-25 | ALCL ALCL 99 Closed Pre Phase | N | N | 240032642 | NOT MATCHED |
| 240007143 | 240004460 | null | 65 | Curative (C) | 2016-12-12 | 2016-12-27 | Carboplatin AUC 6 - 10 | 2 | N | 240032642 | CARBOPLATIN |
| 240007144 | 240004460 | 0 | 87.6 | null | 2013-06-26 | 2013-07-10 | Carboplatin AUC 2 - 5 | N | N | 240032642 | CARBOPLATIN |
| 240007145 | 240004460 | 1.63 | 65.6 | Curative (C) | 2015-05-14 | 2015-05-14 | CHEMO-T TRIAL | 02 | N | 240032642 | TRIAL |
| 240007146 | 240004460 | null | 61 | Disease modification (D) | 2017-05-15 | 2017-06-05 | Chlorambucil + Pred + Rituximab | 99 | N | 240032642 | CHLORAMBUCIL + RITUXIMAB |
| 240007147 | 240004461 | 1.8 | 70.2 | Palliative (P) | 2016-10-15 | 2016-10-19 | Hydroxycarbamide | 01 | Y | 240032656 | HYDROXYCARBAMIDE |
| 240007148 | 240004462 | 1.72 | 125 | Curative (C) | 2016-08-26 | 2016-08-31 | INTERLACE TRIAL | 1 | Y | 240032660 | INTERLACE TRIAL |
| 240007149 | 240004462 | 1.67 | 0 | Curative (C) | 2013-06-05 | 2013-06-23 | R Chlorambucil | 1 | N | 240032660 | CHLORAMBUCIL + RITUXIMAB |
| 240007150 | 240004463 | 1.55 | 68.7 | Palliative (P) | 2014-05-23 | 2014-05-26 | Carboplatin + Etoposide IV 3 day | N | N | 240032665 | CARBOPLATIN + ETOPOSIDE |
| 240007151 | 240004463 | 1.67 | 88.5 | Disease modification (D) | 2016-08-25 | 2016-08-25 | Trial Unspecified | 01 | Y | 240032665 | TRIAL |
| 240007152 | 240004463 | 0 | null | null | 2013-10-16 | 2013-11-08 | Carboplatin AUC 6 - 10 | N | N | 240032665 | CARBOPLATIN |
| 240007153 | 240004464 | 1.56 | 95 | null | 2017-12-26 | 2017-12-27 | Chlorambucil | 2 | N | 240032672 | CHLORAMBUCIL |
| 240007154 | 240004465 | null | 83.7 | Neo-adjuvant (N) | 2016-09-25 | 2016-09-25 | Trial Unspecified | Y | N | 240032678 | TRIAL |
| 240007155 | 240004466 | 0 | 109.7 | Palliative (P) | 2014-12-21 | 2015-01-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240032682 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007156 | 240004467 | null | 66 | Palliative (P) | 2017-05-25 | 2017-05-29 | Chlorambucil | N | N | 240032685 | CHLORAMBUCIL |
| 240007157 | 240004467 | null | 96.6 | Curative (C) | 2017-04-27 | 2017-05-08 | null | N | N | 240032685 | NOT MATCHED |
| 240007158 | 240004468 | 1.72 | 89.8 | Curative (C) | 2017-03-16 | 2017-03-22 | INTERLACE TRIAL | N | N | 240032690 | INTERLACE TRIAL |
| 240007159 | 240004468 | 1.62 | 66.2 | Disease modification (D) | 2016-03-25 | 2016-04-21 | Trial Unspecified | N | N | 240032690 | TRIAL |
| 240007160 | 240004469 | 1.7 | 29.9 | Curative (C) | 2016-09-08 | 2016-09-15 | ALCL ALCL 99 Closed Pre Phase | N | N | 240032695 | NOT MATCHED |
| 240007161 | 240004470 | 1.85 | 71.1 | Disease modification (D) | 2016-06-04 | 2016-06-14 | CHLORAMBUCIL + RITUXIMAB | N | N | 240032698 | CHLORAMBUCIL + RITUXIMAB |
| 240007162 | 240004471 | 1.59 | 64.3 | Neo-adjuvant (N) | null | 2014-04-14 | CARBOPLATIN + ETOPOSIDE | N | N | 240032702 | CARBOPLATIN + ETOPOSIDE |
| 240007163 | 240004472 | 1.6 | 54 | Palliative (P) | 2017-01-03 | 2017-01-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240032704 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007164 | 240004473 | null | 92 | Disease modification (D) | 2016-07-31 | 2016-08-29 | INTERLACE TRIAL | N | null | 240032706 | INTERLACE TRIAL |
| 240007165 | 240004474 | null | null | Palliative (P) | 2017-04-05 | 2017-04-05 | Hydroxycarbamide | 02 | N | 240032707 | HYDROXYCARBAMIDE |
| 240007166 | 240004474 | 1.75 | 70 | null | 2013-12-12 | 2013-12-16 | R Chlorambucil | 2 | N | 240032707 | CHLORAMBUCIL + RITUXIMAB |
| 240007167 | 240013483 | 1.57 | null | Curative (C) | 2014-12-13 | 2014-12-14 | INTERLACE TRIAL | N | N | 240032709 | INTERLACE TRIAL |
| 240007168 | 240004475 | null | 65.1 | Curative (C) | 2015-11-18 | 2015-11-24 | Bendamustine + prednisolone | 02 | N | 240032712 | BENDAMUSTINE |
| 240007169 | 240004476 | 1.75 | 72.5 | Disease modification (D) | 2014-02-17 | 2014-03-02 | R Chlorambucil | 02 | Y | 240032715 | CHLORAMBUCIL + RITUXIMAB |
| 240007170 | 240004477 | 1.6 | 68 | Palliative (P) | 2017-04-12 | 2017-04-28 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240032716 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007171 | 240004477 | 1.6 | 80 | Palliative (P) | 2016-04-12 | 2016-04-13 | Trial Unspecified | 2 | N | 240032716 | TRIAL |
| 240007172 | 240004478 | 1.56 | null | Disease modification (D) | 2013-11-24 | 2013-11-25 | CHLORAMBUCIL + RITUXIMAB | N | N | 240032722 | CHLORAMBUCIL + RITUXIMAB |
| 240007173 | 240004479 | null | 87.1 | Curative (C) | 2016-08-19 | 2016-08-28 | ALCL ALCL 99 Closed Pre Phase | Y | N | 240032724 | NOT MATCHED |
| 240007174 | 240004480 | 1.64 | 65.5 | Palliative (P) | 2013-03-14 | 2013-04-08 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032725 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007175 | 240004480 | null | 93 | Palliative (P) | 2015-04-11 | 2015-04-13 | Hydroxycarbamide | null | null | 240032725 | HYDROXYCARBAMIDE |
| 240007176 | 240004481 | 1.55 | 74 | Palliative (P) | 2016-04-04 | 2016-04-21 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032735 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007177 | 240004481 | 1.68 | null | Curative (C) | 2017-04-01 | 2017-04-01 | Trial Unspecified | N | N | 240032735 | TRIAL |
| 240007178 | 240004482 | 1.72 | 79 | Palliative (P) | 2015-10-22 | 2015-10-22 | CHLORAMBUCIL + RITUXIMAB | 1 | Y | 240032742 | CHLORAMBUCIL + RITUXIMAB |
| 240007179 | 240004482 | 1.75 | 69 | Curative (C) | null | 2017-06-11 | Carboplatin AUC 2 - 5 | N | N | 240032742 | CARBOPLATIN |
| 240007180 | 240004483 | 1.52 | 106.7 | Palliative (P) | null | 2017-02-23 | Carboplatin + Etoposide IV 3 day | N | N | 240032757 | CARBOPLATIN + ETOPOSIDE |
| 240007181 | 240004483 | 1.67 | 65 | Curative (C) | 2015-07-12 | 2015-07-16 | Hydroxycarbamide | N | N | 240032757 | HYDROXYCARBAMIDE |
| 240007182 | 240004484 | 1.67 | 58.9 | Curative (C) | 2017-07-12 | 2017-07-11 | Trial Unspecified | N | N | 240032767 | TRIAL |
| 240007183 | 240004484 | 1.58 | 75.8 | Neo-adjuvant (N) | 2017-11-25 | 2017-11-29 | INTERLACE TRIAL | N | N | 240032767 | INTERLACE TRIAL |
| 240007184 | 240004485 | null | 36.8 | Palliative (P) | null | 2015-04-17 | Chlorambucil | N | N | 240032770 | CHLORAMBUCIL |
| 240007185 | 240010508 | 1.62 | 95 | null | 2017-02-22 | 2017-02-28 | DA 3 + 10 | N | N | 240032771 | DA |
| 240007186 | 240004486 | 1.56 | 54.1 | Curative (C) | 2014-01-05 | 2014-01-11 | Bendamustine +/- Prednisolone | 02 | N | 240032772 | BENDAMUSTINE |
| 240007187 | 240010509 | 1.8 | 22.9 | Palliative (P) | 2015-08-13 | 2015-08-21 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240032776 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007188 | 240004487 | 1.59 | null | Palliative (P) | 2018-04-07 | 2018-05-06 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240032782 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |